International Isotopes Inc. (INIS)
Stock Price Chart
Key Info
| Market Cap | 25.43M |
| Revenue (ttm) | 8.76M |
| Net Income (ttm) | -1.89M |
| Shares Out | 423.71M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Aug 12, 2020 |
| Last Price | $0.0600 |
| Previous Close | $0.0648 |
| Change ($) | -0.0048 |
| Change (%) | -7.41% |
| Day's Open | 0.0645 |
| Day's Range | 0.0615 - 0.0645 |
| Day's Volume | 19,700 |
| 52-Week Range | 0.0421 - 0.0720 |
More Stats
| Market Cap | 25.43M |
| Enterprise Value | 30.15M |
| Earnings Date (est) | n/a |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 423.71M |
| Float | 223.45M |
| EPS (basic) | n/a |
| EPS (diluted) | -0.01 |
| FCF / Share | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | 0.30% |
| Payout Ratio | n/a |
| Shares Short | n/a |
| Short Ratio | n/a |
| Short % of Float | n/a |
| Beta | 0.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | 335.03 |
| PS Ratio | 2.90 |
| PB Ratio | n/a |
| Revenue | 8.76M |
| Operating Income | -910,165 |
| Net Income | -1.89M |
| Free Cash Flow | 75,896 |
| Net Cash | -4.72M |
| Net Cash / Share | -0.01 |
| Gross Margin | 53.24% |
| Operating Margin | -10.39% |
| Profit Margin | -21.60% |
| FCF Margin | 0.87% |
| ROA | -3.64% |
| ROE | -651.61% |
| ROIC | n/a |
Analyst Summary
Analyst Consensus: n/a
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.96 | 10.37 | 7.42 | 6.55 | 7.06 | 7.54 | 6.85 | 7.62 | 9.46 | 6.11 |
| Revenue Growth | -13.63% | 39.73% | 13.25% | -7.22% | -6.3% | 10.04% | -10.14% | -19.45% | 54.93% | - |
| Gross Profit | 4.67 | 4.69 | 3.24 | 2.84 | 2.70 | 2.98 | 2.54 | 2.65 | 3.42 | 2.49 |
| Operating Income | -0.56 | -0.29 | -2.07 | -1.50 | -1.44 | -0.79 | -2.10 | -2.18 | -3.37 | -6.33 |
| Net Income | -1.52 | -0.84 | -3.76 | -1.88 | -1.82 | -1.55 | -2.46 | -2.24 | -5.95 | -6.80 |
| Shares Outstanding | 418 | 411 | 406 | 403 | 398 | 369 | 365 | 360 | 335 | 300 |
| Earnings Per Share | - | - | -0.01 | - | - | - | -0.01 | -0.01 | -0.02 | -0.02 |
| Operating Cash Flow | -0.05 | 0.10 | -0.47 | -0.32 | 0.34 | 0.34 | -1.39 | -2.73 | 0.07 | -4.56 |
| Capital Expenditures | -0.21 | -0.09 | -0.11 | -0.09 | -0.09 | -0.12 | -0.56 | -1.84 | -3.51 | -0.01 |
| Free Cash Flow | -0.26 | 0.01 | -0.58 | -0.41 | 0.25 | 0.22 | -1.96 | -4.57 | -3.44 | -4.57 |
| Cash & Equivalents | 0.58 | 0.83 | 0.80 | 0.31 | 0.40 | 0.56 | 0.46 | 0.55 | 2.10 | 4.24 |
| Total Debt | 3.47 | 4.44 | 3.20 | 6.43 | 4.18 | 4.34 | 4.40 | 2.81 | 0.53 | 3.75 |
| Net Cash / Debt | -2.90 | -3.61 | -2.41 | -6.11 | -3.78 | -3.78 | -3.95 | -2.27 | 1.57 | 0.49 |
| Assets | 15.26 | 12.99 | 12.01 | 11.38 | 11.24 | 10.95 | 12.01 | 12.04 | 11.93 | 11.23 |
| Liabilities | 15.37 | 12.84 | 11.66 | 9.62 | 7.66 | 6.97 | 7.16 | 5.98 | 4.50 | 6.39 |
| Book Value | -2.19 | -1.60 | -1.23 | 1.71 | 3.52 | 3.90 | 4.78 | 5.97 | 7.30 | 4.65 |
Company Profile
Company Details
| Full Name | International Isotopes Inc. |
| Country | United States |
| Employees | 35 |
| CEO | Steve T. Laflin |
Stock Information
| Ticker Symbol | INIS |
| Stock Exchange | US OTC |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Unique Identifier | OTCMKTS: INIS |
| IPO Date | August 14, 1997 |
Description
International Isotopes, Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services. The company operates in five segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, and Radiological Services. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. It offers flood sources, dose calibrators, rod sources, flexible and rigid rulers, spot and pen point markers, and various specialty design items. The Cobalt Products segment produces bulk cobalt; fabricates cobalt capsules for radiation therapy or various industrial applications; and recycles expended cobalt sources. The Radiochemical Products segment produces and distributes various isotopically pure radiochemicals for medical, industrial, and research applications. It provides sodium iodide, cobalt-57, cesium-137, germanium?68, sodium-22, and barium-133 isotopes. The Fluorine Products segment offers products that are used to support the production and sale of gases produced using its fluorine extraction process. The Radiological Services segment decommissions disused irradiation units, performs sealed source exchanges in irradiation and therapy units, and processes gemstones, as well as offers transportation services. The company sells its products directly to end users and distributors. International Isotopes, Inc. was founded in 1995 and is headquartered in Idaho Falls, Idaho.